Marcell A Szász

Summary

Affiliation: Semmelweis University
Country: Hungary

Publications

  1. pmc Prognostic potential of ERG (ETS-related gene) expression in prostatic adenocarcinoma
    A Marcell Szász
    2nd Department of Pathology, Semmelweis University, 93 Ulloi ut, 1091, Budapest, Hungary
    Int Urol Nephrol 45:727-33. 2013
  2. doi request reprint Prognostic significance of claudin expression changes in breast cancer with regional lymph node metastasis
    A M Szasz
    2nd Department of Pathology, Semmelweis University, Ulloi ut 93, Budapest 1091, Hungary
    Clin Exp Metastasis 28:55-63. 2011
  3. doi request reprint [Claudins as prognostic factors of breast cancer]
    Marcell A Szász
    Semmelweis Egyetem, Budapest, Hungary
    Magy Onkol 56:209-12. 2012
  4. pmc Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancers
    Nadine Tung
    Division of Hematology Oncology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    Breast Cancer Res 12:R95. 2010
  5. pmc The potential prognostic value of connexin 26 and 46 expression in neoadjuvant-treated breast cancer
    Ivett Teleki
    1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary
    BMC Cancer 13:50. 2013
  6. doi request reprint A meta-analysis of gene expression-based biomarkers predicting outcome after tamoxifen treatment in breast cancer
    Zsuzsanna Mihály
    1st Department of Pediatrics, Semmelweis University, Budapest, Hungary
    Breast Cancer Res Treat 140:219-32. 2013

Collaborators

  • Janina Kulka
  • Jan Budczies
  • Magdolna Dank
  • Barna Wichmann
  • Balazs Gyorffy
  • Attila Majoros
  • Zsuzsanna Varga
  • Peter Nyirady
  • T Krenacs
  • Zs Nemeth
  • A Marcell Szász
  • Zsuzsanna Mihály
  • Ivett Teleki
  • A M Szasz
  • Nadine Tung
  • Philip Rosen
  • Attila Szendroi
  • Cornelia Leo
  • Cosima Riemenschnitter
  • Andras Lanczky
  • Máté Kormos
  • Shiv Srivastava
  • Holger Moch
  • Barbel Papassotiropoulos
  • Albert Dobi
  • K Dede
  • M Micsinai
  • A M Tokes
  • Cs Jakab
  • L Madaras
  • Zs Baranyai
  • L Lukacs
  • Shiva Gautam
  • Dennis Sgroi
  • Judy E Garber
  • Yosuf Yassin
  • Daniel P Silver
  • Zhigang C Wang
  • Ayodele Buraimoh
  • Jennifer Kaplan
  • Stuart J Schnitt
  • Jane Brock
  • Ji Young Kim
  • Ruiyang Tian
  • Karen Krag
  • Attila M Szász
  • Laura C Collins
  • Robert D Legare
  • Alexander Miron
  • Katharina Fetten
  • Paula D Ryan
  • Andrea L Richardson

Detail Information

Publications6

  1. pmc Prognostic potential of ERG (ETS-related gene) expression in prostatic adenocarcinoma
    A Marcell Szász
    2nd Department of Pathology, Semmelweis University, 93 Ulloi ut, 1091, Budapest, Hungary
    Int Urol Nephrol 45:727-33. 2013
    ..We evaluate the association of both ERG and claudin-4, claudin-5, and beta-catenin expression in tumor tissues of patients with organ-confined and advanced prostatic adenocarcinomas...
  2. doi request reprint Prognostic significance of claudin expression changes in breast cancer with regional lymph node metastasis
    A M Szasz
    2nd Department of Pathology, Semmelweis University, Ulloi ut 93, Budapest 1091, Hungary
    Clin Exp Metastasis 28:55-63. 2011
    ..Loss of claudin junctional molecules might contribute to tumor progression, and certain claudin expression pattern might be of prognostic relevance...
  3. doi request reprint [Claudins as prognostic factors of breast cancer]
    Marcell A Szász
    Semmelweis Egyetem, Budapest, Hungary
    Magy Onkol 56:209-12. 2012
    ..The level of expression of certain claudins can be of prognostic significance in regional lymph node metastases...
  4. pmc Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancers
    Nadine Tung
    Division of Hematology Oncology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    Breast Cancer Res 12:R95. 2010
    ....
  5. pmc The potential prognostic value of connexin 26 and 46 expression in neoadjuvant-treated breast cancer
    Ivett Teleki
    1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary
    BMC Cancer 13:50. 2013
    ..In this study we correlated Cx expression and cell proliferation with disease survival and pathological response to neoadjuvant chemotherapy in breast cancers using existing classification systems...
  6. doi request reprint A meta-analysis of gene expression-based biomarkers predicting outcome after tamoxifen treatment in breast cancer
    Zsuzsanna Mihály
    1st Department of Pediatrics, Semmelweis University, Budapest, Hungary
    Breast Cancer Res Treat 140:219-32. 2013
    ..We evaluated tamoxifen-resistance genes in three independent platforms and identified PGR, MAPT, and SLC7A5 as the most promising prognostic biomarkers in tamoxifen treated patients. ..